Business
Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors - Endpoints News

What the report says
Lilly's 13 acquisitions in 2026, worth about $32B, are recycling cash back to at least 50 biotech venture investors.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Uganda’s informal economy seeks strength in numbersThe Observer
Gen. Saleh Calls For Review Of Caged-Fishing And Coffee-Farming ProjectsWatchdog Uganda
Rubanda Launches Shs40m Road Project to Boost Farm-to-Market AccessNile Post